Yarema Kristin 4
4 · Poseida Therapeutics, Inc. · Filed Apr 12, 2023
Insider Transaction Report
Form 4
Yarema Kristin
President and CEO
Transactions
- Award
Common Stock
2023-04-11+356,836→ 356,836 total - Award
Employee Stock Option (Right to Buy)
2023-04-11+498,325→ 498,325 totalExercise: $2.62Exp: 2033-04-10→ Common Stock (498,325 underlying)
Footnotes (2)
- [F1]Represents shares issuable upon the vesting of restricted stock units granted pursuant to the Issuer's 2022 Inducement Plan. The RSUs are scheduled to vest in four equal annual installments.
- [F2]12.5% of the shares subject to the stock option will vest and become exercisable on the six-month anniversary of the grant date listed in column 3 above, and the remaining shares will vest in 42 equal monthly installments thereafter.